Vertex Pharmaceuticals Inc (VRTX) — Free Cash Flow Generation Index
Vertex Pharmaceuticals Inc (VRTX) has a Free Cash Flow Generation Index of 0.90x as of June 2026. Free cash flow of $1.01 Billion represents 1% of operating cash flow ($1.13 Billion). Explore VRTX capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Vertex Pharmaceuticals Inc Free Cash Flow Generation Index (1993–2025)
Historical FCF Generation Index trend for Vertex Pharmaceuticals Inc across 12 annual periods. For the full cash flow conversion analysis, see Vertex Pharmaceuticals Inc cash flow conversion.
Annual Free Cash Flow Generation for Vertex Pharmaceuticals Inc (1993–2025)
Year-by-year Free Cash Flow Generation Index for Vertex Pharmaceuticals Inc. Check VRTX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.88x | $3.19 Billion | $3.63 Billion | $437.60 Million | ▼ -5.1% |
| 2023 | 0.93x | $3.28 Billion | $3.54 Billion | $258.40 Million | ▼ -2.5% |
| 2022 | 0.95x | $3.93 Billion | $4.13 Billion | $204.70 Million | ▲ +4.3% |
| 2021 | 0.91x | $2.41 Billion | $2.64 Billion | $235.00 Million | ▼ -1.0% |
| 2020 | 0.92x | $2.99 Billion | $3.25 Billion | $259.80 Million | ▼ -3.3% |
| 2019 | 0.95x | $1.49 Billion | $1.57 Billion | $75.45 Million | ▲ +2.9% |
| 2018 | 0.92x | $1.17 Billion | $1.27 Billion | $95.52 Million | ▲ +33.5% |
| 2017 | 0.69x | $585.52 Million | $844.94 Million | $259.42 Million | ▼ -8.9% |
| 2016 | 0.76x | $179.54 Million | $236.10 Million | $56.56 Million | ▲ +3.5% |
| 2012 | 0.73x | $196.70 Million | $267.84 Million | $71.14 Million | ▲ +114.8% |
| 2011 | 0.34x | $49.14 Million | $143.74 Million | $94.59 Million | ▼ -56.8% |
| 1993 | 0.79x | $6.80 Million | $8.60 Million | $1.80 Million | — |